Lung cancer pill cuts risk of death by half, says ‘thrilling’ study
by Andrew Gregory Health editor in Chicago from Science | The Guardian on (#6C1TQ)
Taking the drug osimertinib once a day after surgery reduces chance of patients dying by 51%, trials show
A pill taken once a day cuts the risk of dying from lung cancer by half, according to thrilling" and unprecedented" results from a decade-long global study.
Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world's largest cancer conference showed.
Continue reading...